Phosphoric Acid

Phosphoric Acid

SCHEMBL549605

O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[W+6].[W+6].[W+6].[Zr+4].[Zr+4].[Zr+4]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SLC34A1 Q06495 1/20 0.42
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phosphoric Acid SCHEMBL31276655 0.94 SLC34A1 (0.46) SLC34A1LMNA
Phosphoric Acid SCHEMBL64654 0.94 SLC34A1 (0.46) SLC34A1LMNA
Phosphoric Acid SCHEMBL31742546 0.94
Phosphoric Acid SCHEMBL490889 0.94 SLC34A1 (0.46) SLC34A1LMNA
Phosphoric Acid SCHEMBL8820900 0.88 SLC34A1 (0.42) SLC34A1LMNA
Phosphoric Acid SCHEMBL6473013 0.88 SLC34A1 (0.55) SLC34A1LMNA
Phosphoric Acid SCHEMBL10715778 0.88 SLC34A1 (0.42) SLC34A1LMNA
Phosphoric Acid SCHEMBL10874112 0.88 SLC34A1 (0.42) SLC34A1LMNA
Phosphoric Acid SCHEMBL5017925 0.88 SLC34A1 (0.42) SLC34A1LMNA
Phosphoric Acid SCHEMBL2989706 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122060319-A Low-expansion-coefficient high-temperature nylon composite material for electronic packaging and preparation method thereof 广东奇德新材料股份有限公司 2026-05-19 CN claimed
US-12628652-B2 Supporting sealant layer structure for stacked die application TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2026-05-12 US claimed
US-20260001301-A1 FOAMED RESIN INSULATION MATERIAL, AND METHOD FOR MANUFACTURING SAME MEISEI KOGYO KK (JP) 2026-01-01 US claimed
US-12500093-B2 Composite particulates for use as part of a supporting fill mixture in a semicondutor substrate stacking application TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2025-12-16 US claimed
EP-4588966-A1 FOAMED RESIN INSULATION MATERIAL, AND METHOD FOR MANUFACTURING SAME Meisei Industrial Co., Ltd. (JP) 2025-07-23 EP claimed
US-20240162051-A1 COMPOSITE PARTICULATES FOR USE AS PART OF A SUPPORTING FILL MIXTURE IN A SEMICONDUTOR SUBSTRATE STACKING APPLICATION TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2024-05-16 US claimed
CN-117995695-A Method of forming integrated circuit 台湾积体电路制造股份有限公司 2024-05-07 CN claimed
WO-2024063440-A1 LEAD-FREE LOW-TEMPERATURE FIRED GLASS FRIT 주식회사 베이스 2024-03-28 WO claimed
WO-2023146355-A1 GLASS FRIT COMPOSITION FOR VACUUM GLASS SEALING 주식회사 베이스 2023-08-03 WO claimed
US-11394365-B2 Saw device with composite substrate for ultra high frequencies QUALCOMM INCORPORATED (US) 2022-07-19 US claimed
US-20180265358-A1 METHOD FOR PRODUCING ZIRCONIUM TUNGSTEN PHOSPHATE NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) 2018-09-20 US claimed
US-9815735-B2 Lead-free glass and sealing material CENTRAL GLASS COMPANY, LIMITED (JP) 2017-11-14 US claimed
EP-3040319-A1 LEAD-FREE GLASS AND SEALING MATERIAL Central Glass Company, Limited (JP) 2016-07-06 EP claimed
US-20160168017-A1 Lead-Free Glass and Sealing Material CENTRAL GLASS COMPANY, LIMITED (JP) 2016-06-16 US claimed
EP-1942084-B1 Glass plate with glass frit structure SAMSUNG DISPLAY CO LTD (KR) 2014-12-31 EP claimed
US-8110982-B2 Organic light emitting diode display device and method of fabricating the same SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-02-07 US claimed
US-7871949-B2 Glass plate with glass frit structure SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-01-18 US claimed
US-20100044730-A1 Organic light emitting diode display device and method of fabricating the same SAMSUNG DISPLAY CO., LTD. (KR) 2010-02-25 US claimed
US-20080164462-A1 Light emitting unit between first and second substrate; sealing material of vanadium glass frit; manufacturing costs are low and deterioration of the light emitting unit prevented; long lifetime SAMSUNG SDI CO., LTD. (KR) 2008-07-10 US claimed
EP-1942084-A2 Glass plate with glass frit structure Samsung SDI Co., Ltd. (KR) 2008-07-09 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12628652-B2 Supporting sealant layer structure for stacked die application DSG1, CDH1, GJB2 SLC34A1 4755/4885LMNA 753/4885
US-20260001301-A1 FOAMED RESIN INSULATION MATERIAL, AND METHOD FOR MANUFACTURING SAME INCENP, EWSR1, FIP1L1 SLC34A1 3084/4885LMNA 435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.